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Abstract
Purpose We prospectively investigated whether high
intramedullary SI and contrast [gadolinium-diethylene-
triamine-pentaacetic acid (Gd-DTPA)] enhancement in
magnetic resonance imaging (MRI) are associated with
postoperative prognosis in cervical compressive myelopa-
thy (CCM) patients.
Methods Seventy-four patients with ventral cord com-
pression at one or two levels underwent anterior cervical
discectomy and fusion (ACDF) for CCM between March
2006 and June 2009. The mean follow-up period was
39.7 months (range, 12.7–55.7 months). The cervical cord
compression ratio and clinical outcomes were measured
using Japanese Orthopedic Association (JOA) scores for
cervical myelopathy. Patients were classified into three
groups based on the SI change in T2WI, T1-weighted
images (T1WI), and contrast (Gd-DTPA) enhancement.
Results The mean preoperative and postoperative JOA
scores were 10.5 ± 2.9 and 15.0 ± 2.1 (P \ 0.05),
respectively. The mean recovery ratio of the JOA score was
70.9 ± 20.2%. There were statistically significant differ-
ences in postoperative JOA and recovery ratio among three
groups. However, post-surgical neurological outcomes
were not associated with age, symptom duration, preoper-
ative JOA, and cord compression.
Conclusions We found that intramedullary SI change is
a poor prognostic factor and the intramedullary contrast
(Gd-DTPA) enhancement on preoperative MRI should be
viewed as the worst predictor of surgical outcomes in
cervical myelopathy. Contrast (Gd-DTPA) enhancement
and postoperative MRI are useful for identifying the
prognosis of patients with poor neurological recovery.
Keywords Cervical compressive myelopathy  Magnetic
resonance imaging (MRI)  Increased signal intensity 
Intramedullary Gd-DTPA enhancement
Introduction
Cervical myelopathy is a diagnosis with a basis in radicular
and myelopathic syndromes of degeneration. Magnetic
resonance imaging (MRI) has been used, not only to depict
how the spinal cord is compressed anatomically, but also to
reflect the pathological changes within the spinal cord
through changes in signal intensity (SI) in patients with
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cervical myelopathy [8, 13]. Additionally, contrast [gado-
linium-diethylene-triamine-pentaacetic acid (Gd-DTPA)]
enhanced MRI provides information about the integrity of
the spinal cord. However, the application of any contrast
medium has not been commonly utilized in the imaging of
patients with cervical degenerative diseases.
Several studies have reported that patients with increased
SI in T2WI tend to have poorer prognoses after surgery [8, 9,
13, 17]; however, other studies have reported no such asso-
ciation [22]. Several studies have reported contrast (Gd-
DTPA) enhancement in MR images in patients with cervical
myelopathy [3, 11]. While previous studies have examined
both high SI changes in T2WI and contrast enhancement in
T1WI, there have been few studies comparing the prognostic
significance of these imaging parameters.
This study prospectively evaluates the relevance of
signal intensity changes to the neurological outcomes of
patients with cervical compressive myelopathy (CCM)
caused by intervertebral disc herniation or osteophyte
formation at one or two levels. Additionally, this study
investigates the usefulness of contrast-enhanced MRI in
patients with cervical myelopathy.
Patients and methods
One hundred and forty-three consecutive patients with
cervical myelopathy were treated at our institution from
March 2006 to June 2009. Of the 143 patients treated, 74
(51.7%) consecutive patients with ventral cord compres-
sion at one or two levels of the spine caused by interver-
tebral disc herniation or bony spur were enrolled in this
study. The concomitant diagnoses causing CCM were
cervical spondylotic myelopathy in 48 patients and cervical
disc herniation in 26 patients. Patients with cervical mye-
lopathy because of cervical ossification of the posterior
longitudinal ligament were excluded. The 74 patients (48
men, 26 women; mean age, 51.3 years; from 26 to
69 years) underwent anterior cervical discectomy and
fusion (ACDF). Of these patients, 45 underwent one level
ACDF as these patients had a diagnosis of one level CCM
at C3-4 (8 patients), C4-5 (9), C5-6 (21), or C6-7 (7). One
iliac bone and Atlantis plate (Medtronic Sofamor-Danek,
Memphis, TN) were used in 29 cases, while a Cervios cage
(Synthes, Oberdorf, Germany) and Atlantis plate were used
in 16 cases. Twenty-nine patients underwent a two level
ACDF, as these patients were diagnosed with a two level
CCM at C3-4-5 (7), C4-5-6 (8), or C5-6-7 (14). For this
ACDF procedure, two autologous iliac bones and an
Atlantis plate were used in each of the cases. A diagnosis
of cervical myelopathy was assigned with radiological
confirmation MRI, and the diagnosis was required to be in
one or more ‘‘upper motor neuron’’ domains (e.g.,
spasticity, hyperreflexia, positive Babinski sign) based on a
neurological examination.
Patients with central cord syndrome, other acute trau-
matic cord injuries, other neurological disorders (e.g.,
cerebral palsy, multiple sclerosis), and instability of the
cervical spine as diagnosed with radiographs were exclu-
ded from this study. Patients whose symptoms of mye-
lopathy were precipitated following traumatic injury with a
pre-existing CCM diagnosis were also excluded.
Radiological assessment
All patients underwent high resolution MRI using a 1.5 T
Signa (Siemens Medical System) unit with a surface coil.
T1- and T2-weighted sagittal views of the cervical spine were
obtained using a spin echo sequence for the T1-weighted
images, and a first spin echo sequence was used for the
T2-weighted images. The slice thickness was 3 mm in the
sagittal and axial planes, and the acquisition matrix was
448 9 269. The sequence parameters were repetition time
(TR) 450 ms/echo time (TE) 9.5 ms for T1-weighted and TR
3,790 ms/TE 114 ms for T2-weighted MRI. After acquisition
of the precontrast MRI, an intravenous injection of Gd-DTPA
(Magnevist, Schering; 0.1 mmol/kg body weight) was
administered. The postcontrast MR images were performed
using the same parameters and protocol as the noncontrast
MRI. Additional parameters included TR 690 ms/TE 11 ms
for the Gd-DTPA enhancement in the T1-weighted images.
Increased signal intensity was defined as a high-intensity area
in contrast with the adjacent isointensity portion of the spinal
cord in the sagittal and axial plane [25]. We defined Gd-DTPA
enhancement as a demarcation relatively clear from the sur-
rounding cord parenchyma where it was found [18].
In the case of preoperative cord signal changes, follow-
up MRIs were completed at 3 or 6, and again at 12 months
after surgery. If the intramedullary contrast (Gd-DTPA)
enhancement appeared preoperatively, follow-up assess-
ments were performed with contrast-enhanced MRI. The
interval change of intramedullary high SI and contrast
enhancement on follow-up MRI was compared with that on
preoperative images.
MR imaging factors
Three patterns of spinal cord signal intensity on
T1-weighted images, T2-weighted images, and Gd-DTPA
enhanced MR images were observed. Specifically, group A
(N/N) displayed normal intensity on both T1- and
T2-weighted images; group B (N/Hi) displayed no intra-
medullary signal intensity abnormalities on the T1-weighted
images and high SI on the T2-weighted images; and group
C (N/Hi/Gd) displayed no intramedullary signal intensity
abnormalities on the T1-weighted images, high SI on the
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T2-weighted images, and an enhanced contrast (Gd-DTPA)
image (Figs. 1, 2, 3).
By comparing the preoperative and postoperative signal
change on T2-weighted images, patients with high SI
before surgery were classified into two groups after the
surgery: reversible group (those whose SI had decreased)
and stationary group (those whose SI was unchanged). We
evaluated the degree of signal intensity according to grade
0, for no change in signal intensity on T2-weighted MR
images; grade 1, for light intensity change; and grade 2 for
a bright signal, clearly distinguishable from that of grade 1
[15]. Spinal cord signal intensity changes were evaluated
by two neuroradiologists (J.H.L. and W.H.C.) who were
blinded to the patients’ clinical data. They independently
interpreted the T2 and T1-weighted images to determine
the presence of signal intensity changes and contrast
enhancement in the spinal cord. If they disagreed on the
radiological finding in any patient, the case was excluded
from this study.
Compression ratio
The compression ratio was measured by dividing the
smallest anteroposterior dimension of the spinal cord by
the broadest transverse diameter at the same level on axial
MRI scans (Fig. 4).
Functional outcome measures
Patient neurological outcomes were evaluated according
to the Japanese Orthopedic Association (JOA) scale for
cervical myelopathy (Table 1) [7].
Statistical analysis
For nonparametric analysis, the Mann–Whitney U test was
used to analyze differences between the two groups, and
the Kruskal–Wallis test was used to analyze differences
among the three groups. All statistical analyses were con-
ducted using MedCalc version 11.1 software (MedCalc,
Mariakerke, Belgium). P values \0.05 were considered
statistically significant.
Results
All 74 participants underwent anterior cervical discectomy
and fusion. The mean follow-up time was 39.7 months
(range, 12.7–55.7 months) after surgery. The mean pre-
operative and postoperative JOA scores were 10.5 ± 2.9
and 15.0 ± 2.1, respectively (P \ 0.05). Neurological
outcomes for all patients with CCM were improved
through ACDF. The mean recovery rate was 70.9 ±
20.2%.
Fifty (67.6%) of the 74 participants experienced
increased signal intensity in the spinal cord on the
T2-weighted MRI, while 24 (32.4%) did not. Additionally,
16 (32%) of the 50 patients experiencing increased intra-
medullary signal changes displayed contrast (Gd-DTPA)
enhancements on the MR images. All contrast-enhance-
ment MR findings were observed in the intramedullary
signal change on the T2WI MR images.
Fig. 1 The MRI of a 49-year-old woman with cervical compressive
myelopathy (13 points on JOA score) was caused by a cord
compression at C5/6 and C6/7. No spinal cord abnormality is seen
in the T1 and T2-weighted image. The patient was categorized into
group A (N/N)
Fig. 2 Magnetic resonance imaging of a 34-year-old man with
cervical myelopathy (11 points on JOA score). The sagittal
T1-weighted image displays no intramedullary SI change. And
T2-weighted image reveals increased SI at C4/5, where the cord
compression can be seen. The signal intensity is grade 2. The patient
was arranged into group B (N/Hi)
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Age, preoperative JOA, symptom duration, and spinal
cord compression
The mean ages of the participants were 50.0 ± 8.3 years in
group A (N/N), 53.5 ± 9.9 years in group B (N/Hi), and
48.4 ± 8.9 years in group C (N/Hi/Gd). The preoperative
JOA scores were 11.6 ± 2.2 for group A, 10.1 ± 3.2 for
group B, and 9.8 ± 3.0 for group C. The duration of pre-
operative symptoms ranged from 3 to 60 weeks (mean,
9.8 ± 10.6 weeks). The duration of symptoms was 6.2 ±
7.9 weeks in group A, 10.4 ± 11.5 weeks in group B, and
13.9 ± 10.9 weeks in group C. The mean cord compression
ratios for groups A, B, and C were 34.5 ± 7.8, 31.0 ± 7.6,
and 35.0 ± 10.4%, respectively. Statistical analyses
revealed no significant group differences in age, preopera-
tive JOA scores, symptom duration, or cord compression
(Table 2).
Postoperative JOA and neurological outcomes
The respective postoperative JOA scores and recovery
ratios (%) were 16.2 ± 0.8/82.4 ± 16.7% for group A,
14.6 ± 2.5/69.1 ± 20.8% for group B, and 13.9 ± 1.7/
57.5 ± 14.0% for group C. Significant differences in
postoperative JOA scores and recovery ratios were found in
the three groups (P \ 0.05) (Table 2). That is, neurological
outcomes improved significantly according to the level of
preoperative intramedullary signal changes or contrast
enhancements experienced by the group.
Follow-up magnetic resonance images
All patients who experienced intramedullary signal chan-
ges on their preoperative MR images were re-examined at
3 or 6, and 12 months after surgery. At the time of the
postoperative MRI, 19 of the 50 participants with intra-
medullary SI exhibited a reversal of SI, while 31 patients
did not. The mean recovery ratio of the reversal group was
75.9 ± 14.3%, which was better than that of the other 31
patients (59.0 ± 19.7%), and the difference between these
groups was statistically significant (P \ 0.05) (Table 3).
Additionally, in 17 (50%) of the 34 participants displaying
preoperative intramedullary high signal intensity the signal
intensity decreased substantially postoperatively, while
Fig. 3 Magnetic resonance
imaging of a 50-year-old man
with cervical compressive
myelopathy (10 points on JOA
score). The sagittal T1-weighted
image shows no signal
abnormality on the spinal cord.
The sagittal T2-weighted image
shows a high signal change at
C4/5, where the signal intensity
grade 1 is seen. Intramedullary
Gd-DTPA enhancement reveals
a demarcation from the
surrounding cord parenchyma.
The patient was classified into
group C (N/Hi/Gd)
Fig. 4 The compression ratio of the spinal cord is measured at the
smallest sagittal diameter of the spinal cord divided by the broadest
transverse diameter at the same level
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only 2 (12.5%) of the 16 patients experiencing intramed-
ullary high SI and contrast enhancement preoperatively had
the signal intensity decrease postoperatively.
At postoperative contrast enhanced MRI, 11 (68.8%) of
the 16 participants displaying preoperative contrast (Gd-
DTPA) enhancement experienced a substantial reduction in
the intramedullary contrast enhancement. Intramedullary
contrast enhanced outcomes were reduced generally within
1 year (average 8.4 months) following surgery. In five
cases, the contrast-enhanced outcomes remained, but
decreased slightly in the extent of the detected area and the
degree of signal intensity 1 year following decompressive
surgery. These changes could not be evaluated statistically
due to the small number of patients undergoing follow-up
contrast enhanced MRI.
Discussion
Many authors have recommended surgical decompression
for the treatment of CCM [1, 7, 10]. Although the ‘‘best
practice’’ approach to the treatment of CCM remains
controversial, for patients with both kyphosis and ventral
compression the use of a ventral surgical approach may be
the most beneficial [6, 23]. Improvement rates following
decompression surgery for the treatment of cervical mye-
lopathy have been reported to range from 51 to 85% [6,
12]. In the current study, cervical myelopathic patients who
experienced ventral cord compression at either one or two
levels, who then underwent ACDF were followed pro-
spectively. The overall recovery ratio based on the JOA
scores of these participants was 70.9%, which is compati-
ble with estimates of recovery published in other studies
[6].
Many authors have investigated the association between
SI changes and surgical outcomes following the surgical
treatment of CCM [8, 9, 13, 15, 25]. Yukawa et al. [25]
reported that MRI outcomes associated with intramedullary
high SI are indicators of poor prognosis. According to
several other studies, the signal changes on preoperative
MR images have been observed variously range from 28.7
to 83% [16, 24]. In this study, we found that preoperative
intramedullary signal changes were present in 67.6% of
Table 1 Scoring system for cervical myelopathy proposed by the
Japanese Orthopaedic Association (JOA)
I. Upper extremity function
0. Impossible to eat with either spoon or chopsticks
1. Possible to eat with spoon but not with chopsticks
2. Possible to eat with chopsticks but inadequately
3. Possible to eat with chopsticks but awkwardly
4. Normal
II. Lower extremity function
0. Impossible to walk
1. Need cane or aid on flat ground
2. Need cane or aid only on stairs
3. Possible to walk without cane or aid but slowly
4. Normal
III. Sensory function
A. Upper extremity
0. Apparent sensory loss
1. Minimal sensory loss
2. Normal
B. Lower extremity (same as A)
C. Trunk (same as A)
IV. Bladder function
0. Complete retention
1. Sense of retention or dribbling or straining
2. Urinary frequency or hesitancy
3. Normal
Recovery rate %ð Þ ¼ Postoperative JOA scorepreoperative JOA scoreð Þ100
17 full scoreð Þpreoperative JOA score
Table 2 Clinical features and surgical outcome according to group
status
Group A
(n = 24)
Group B
(n = 34)
Group C
(n = 16)
P
Age (years) 50.0 ± 8.3 53.5 ± 9.9 48.4 ± 8.9 0.417
Symptom
duration
(weeks)
6.2 ± 7.9 10.4 ± 11.5 13.9 ± 10.9 0.068
Compression
ratio (%)
34.5 ± 7.8 31.0 ± 7.6 35.0 ± 10.4 0.174
Preoperative
JOA
11.6 ± 2.2 10.1 ± 3.2 9.8 ± 3.0 0.080
Postoperative
JOA
16.2 ± 0.8 14.6 ± 2.5 13.9 ± 1.7 0.001
Recovery rate
(%)
82.4 ± 16.7 69.1 ± 20.8 57.5 ± 14.0 \0.001
JOA Japanese Orthopedic Association score
Table 3 Clinical characteristics and surgical outcomes according to
group status of postoperative alternations in signal intensity
Reversible group
(n = 19)
Stationary group
(n = 31)
P
Age (years) 50.1 ± 11.1 53.0 ± 8.9 0.3215
Symptom duration
(weeks)
9.4 ± 13.5 12.8 ± 9.7 0.3003
Compression ratio
(%)
32.5 ± 8.2 32.2 ± 9.1 0.9080
Preoperative JOA 11.0 ± 2.1 9.4 ± 3.4 0.0716
Postoperative JOA 15.5 ± 1.1 13.7 ± 2.6 0.0048
Recovery rate (%) 75.9 ± 14.3 59.0 ± 19.7 0.0021
JOA Japanese Orthopedic Association score
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patients enrolled in this study. Clinical outcomes were
significantly worse for patients whose MR images dem-
onstrated intramedullary high signal intensity changes.
The purpose of this study was to clarify the usefulness of
contrast (Gd-DTPA) enhancement on preoperative MRI
and the relationship between the changes in signal inten-
sities and the neurological outcomes. Gd-DTPA is a bio-
logically inert substance, and it diffuses passively through
the blood–cord barrier (BCB) into the extracellular space
[21]. Gd-DTPA enhancement can indicate a disruption to
the parenchyma of the spinal cord and a disturbance in the
BCB of the spinal cord [2]. Generally, intramedullary
Gd-DTPA enhanced MRI reveal intramedullary lesions,
including intramedullary tumors, multiple sclerosis, sar-
coidosis, myelitis, and spinal cord infarction [2, 14, 19].
Recently, intramedullary Gd-DTPA enhanced MRI find-
ings were known to appear in spinal cord injuries [14, 19].
Shimada et al. [14] observed a contrast enhancement of the
injured cords of patients who had experienced a spinal cord
injury. However, contrast enhancement of the spinal cord
occurs even more rarely in patients with chronic degener-
ative processes of the spinal cord [3, 4, 18]. To our
knowledge, Takahashi et al. [17] were first to describe MR
outcomes of intramedullary Gd-DTPA enhancement in
patients with cervical myelopathy. There are few reports of
the prognostic value of enhancement MRI with respect to
clinical outcomes in patients with cervical myelopathy
[11]. Ozawa et al. [11] discussed mainly the prevalence and
morphologic findings of intramedullary enhancement in
cervical myelopathy and reported intramedullary contrast
enhancement was indicative of worse prognosis in cervical
myelopathy rather than the severity of preoperative
symptoms. However, they evaluated the cervical myelo-
pathic patients treated at various affected levels and by
treatment modalities with either anterior fusion or posterior
laminoplasty using Kurokawa’s method.
Many authors demonstrated that the surgical outcomes
of cervical myelopathy have been reported variously
depending on affected level number, treatment modality,
and surgical options including anterior cervical fusion,
posterior fusion, or cervical laminoplasty [5, 20]. There has
been no study to compare the clinical outcome of none SI
change and intramedullary increased SI change to that of
contrast (Gd-DTPA) enhancement. In present study, we
evaluated the neurological outcomes in patients with cer-
vical myelopathy and ventral cord compression at one or
two levels, who underwent ACDF. Patients with contrast
(Gd-DTPA) enhancement on T1-weighted MRI had lower
postoperative JOA scores and JOA recovery ratios in
comparison with patients with intramedullary high signal
changes on T2-weighted MRI or without enhanced signal
intensity preoperatively (Fig. 5). Our findings suggest that
the intramedullary contrast enhancement on preoperative
MRI should be considered as the worst predictor of sur-
gical outcomes in cervical myelopathy.
The mechanism of contrast (Gd-DTPA) enhancement
has been not fully explained in patients with cervical
myelopathy. We speculate that a breakdown of the BCB
may develop due to compression leading to spinal cord
swelling and to leakage of Gd-DTPA. We expected that the
Fig. 5 a Preoperative T2-weighted MRI of a 48-year-old male
patient with spinal cord compression at C5–C6 and a JOA score of 14.
b Intramedullary Gd-DTPA enhancement below the region of the
marked compressed cord within intramedullary SI. c MRI of the
patient from B, 6 months following the cervical anterior discectomy
and fixation with successful decompression of the spinal cord. The
intramedullary SI change remained. The patient’s JOA score was 16.
The recovery rate was 66.7%. d The intramedullary Gd-DTPA
enhancement regressed after decompressive surgery leaving a partial
enhancement at C5–C6
2272 Eur Spine J (2011) 20:2267–2274
123
preoperative symptom duration would be correlated with
the existence of intramedullary SI and contrast enhance-
ment. In this study, all contrast (Gd-DTPA) enhancement
was observed below the region of the compressed cord;
however, the preoperative mean cord compression ratio
and symptom duration were not significantly associated
with group status. Thus, we believe that contrast (Gd-
DTPA) enhancement was derived from the compression of
the spinal cord, but not associated with time course or cord
compression severity. Cabraja et al. [4] reported that the
contrast enhancement of cervical myelopathy was likely
due to a mild reactive gliosis on histopathological findings.
Based on the results of this study, it appears that intra-
medullary high SI and contrast enhancement may disap-
pear or decrease in intensity due to improvement in the
pathological condition as a result of the decompression
surgery. The regression of intramedullary signal changes in
patients with hyperintensity T2WI can be regarded as a
predictor of improved outcome following surgery. Several
studies have reported that patients whose SI decreased
following surgery had better neurological outcomes post-
operatively than patients whose SI did not decrease [16,
24]. However, other studies have reported that postopera-
tive alterations in SI were uncorrelated with postoperative
outcomes [22]. To investigate the relationship between the
neurological outcomes and the changes in signal intensities
at follow-up MRI, patients having high SI before surgery
were classified into two groups depending on the post-
surgical regression of high SI. After the decompression
surgery, intramedullary high SI was lessened in 19 patients
(38%) and remained unchanged in 31 (62%). The reversal
group displayed more improvements in JOA recovery
ratios than the non-reversal group. Additionally, the
reversal rate of the signal change of patients with preop-
erative intramedullary high signal intensity showed greater
changes than those with contrast enhancement. Thus, it can
be concluded that intramedullary high signal intensity
reflects greater recuperative potential and contrast
enhancement indicates less recuperative potential in
patients with CCM.
Conclusion
Preoperative intramedullary high SI change and contrast
(Gd-DTPA) enhancement on MR images were significantly
associated with neurological status after surgery. Intra-
medullary SI change is a poor prognostic factor and the
intramedullary contrast enhancement on preoperative MRI
should be viewed as the worst predictor of surgical out-
comes in cervical myelopathy. Contrast (Gd-DTPA)
enhancement in CCM implies a severe form of cervical
myelopathy. The regression of signal changes in patients
with intramedullary high SI before surgery reflects
improved neurological outcomes after surgery. We
observed that the reversal rate of the signal change of
patients with preoperative intramedullary high signal
intensity showed greater changes than those with contrast
enhancement. We can conclude that intramedullary high
signal intensity indicates greater recuperative potential and
contrast enhancement less recuperative potential in cervical
myelopathy. We consider that contrast (Gd-DTPA)
enhancement and postoperative MRI are useful for identi-
fying the prognosis of patients with poor neurological
recovery.
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